BridgeMD
New treatment option for Bladder (Urothelial, Transitional Cell) Cancer
Official title Treatment Expedition With MRI Processing and Optimization for Muscle Invasive Bladder Cancer
ClinicalTrials.gov ID: NCT07067749
What this study is testing
What is Circulating tumour DNA levels assessment?
Circulating tumour DNA levels assessment is an investigational medicine, being studied as a potential treatment for bladder (urothelial, transitional cell) cancer.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The TEMPO-MIBC trial is a phase III, single-center, two-arm, randomized, controlled trial. Its primary objective is to evaluate the efficacy of a simplified diagnostic and treatment pathway for muscle-invasive bladder cancer (MIBC).
- Phase 3: a large, late-stage study
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Clinical suspicion of muscle invasive bladder cancer at cystoscopy and pre-cystoscopy imaging
You likely can't join if
- Anticipated survival \< 3 months due to comorbidities
- Pregnant patients
- Breastfeeding patients
- Previous chemotherapy within 6 weeks
- Previous radiotherapy withing 6 weeks
- Previous TURBt within 6 weeks
See the full eligibility criteria
- Clinical suspicion of muscle invasive bladder cancer at cystoscopy and pre-cystoscopy imaging
- Anticipated survival \< 3 months due to comorbidities
- Pregnant patients
- Breastfeeding patients
- Previous chemotherapy within 6 weeks
- Previous radiotherapy withing 6 weeks
- Previous TURBt within 6 weeks
- Severe renal impairment (eGFR \< 40 mL/min/1.73 m2)
- non MRI-compatible metal implants
- Claustrophobia
- Denial of written consent to participate in the study
The study team makes the final eligibility decision.
Where it's taking place
- Rome, RM, Italy
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Rome, RM, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.